SARC016: Phase II study of everolimus in combination with bevacizumab in sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors (MPNST).

被引：21
|
作者：
Widemann, Brigitte C.
Meyer, Christian Frederick
Cote, Gregory Michael
Chugh, Rashmi
Milhem, Mohammed M.
Van Tine, Brian Andrew
Kim, AeRang
Turpin, Brian
Dombi, Eva
Jayaprakash, Nalini
Okuno, Scott H.
Helman, Lee J.
Onwudiwe, Ndidi
Steinberg, Seth M.
Reinke, Denise K.
Cichowski, Karen
Perentesis, John Peter
机构：
[1] Natl Canc Inst, Ctr Canc Res, Bethesda, MD USA
[2] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Univ Michigan, Hlth Syst, Ann Arbor, MI 48109 USA
[5] Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
[6] Washington Univ, St Louis, MO 63110 USA
[7] Ctr Canc & Blood Disorders, Washington, DC USA
[8] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[9] Natl Canc Inst, Pediat Oncol Branch, Bethesda, MD USA
[10] NIH, Pediat Oncol Branch, Natl Canc Inst, Bldg 10, Bethesda, MD 20892 USA
[11] Mayo Clin, Rochester, MN USA
[12] SARC, Ann Arbor, MI USA
[13] NIH, Biostatist & Data Management Sect, Natl Canc Inst, Bldg 10, Bethesda, MD 20892 USA
[14] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[15] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.11053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11053
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Radiation Therapy in Management of Sporadic and Neurofibromatosis Type 1 (NF1) Associated Malignant Peripheral Nerve Sheath Tumors (MPNST)
    Kahn, J.
    Gillespie, A.
    Ondos, J.
    Dombi, E.
    Camphausen, K.
    Widemann, B.
    Kaushal, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S638 - S638
  • [2] SARC006: Phase II trial of chemotherapy in sporadic and neurofibromatosis type 1 (NF1)-associated high-grade malignant peripheral nerve sheath tumors (MPNSTs).
    Widemann, Brigitte C.
    Reinke, Denise K.
    Helman, Lee J.
    Ludwig, Joseph A.
    Schuetze, Scott
    Staddon, Arthur P.
    Milhem, Mohammed M.
    Rushing, Daniel A.
    Moertel, Christopher L.
    Goldman, Stewart
    Livingston, Michael B.
    Wagner, Lars M.
    Rodler, Eve T.
    Dombi, Eva
    Perry, Arie
    Annunziata, Christina M.
    Long, Lauren
    Viskochil, David
    Steinberg, Seth M.
    Baker, Laurence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Malignant peripheral nerve sheath tumour (MPNST) arising in plexiform neurofibroma in a neurofibromatosis type I (NF1) patient
    Sykaras, A.
    Gioti, E.
    Stavrinou, N.
    Dolkiras, P.
    Christofidis, K.
    Kouvidou, C.
    VIRCHOWS ARCHIV, 2021, 479 : S307 - S307
  • [4] SARC023: Phase I/II trial of ganetespib in combination with sirolimus for refractory sarcomas and malignant peripheral nerve sheath tumors (MPNST).
    Kim, AeRang
    Reinke, Denise K.
    Cichowski, Karen
    Perentesis, John Peter
    Wolters, Pamela
    Martin, Stacl
    Dombl, Eva
    Steinberg, Seth M.
    Widemann, Brigitte C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NFI):: Diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene
    Friedrich, RE
    Kluwe, L
    Fünsterer, C
    Mautner, VF
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1699 - 1702
  • [6] Impact of Demographics and Socioeconomic Factors on Likelihood of Receiving Surgery for Neurofibromatosis 1 (NF1)-Associated Malignant Peripheral Nerve Sheath Tumors (MPNST)
    Munnangi, Pujita
    Gingrich, Alicia
    Chiang, Yi-Ju
    Lyu, Heather G.
    Lillemoe, Heather
    Scally, Christopher
    Keung, Emily Z.
    Roland, Christina L.
    Hunt, Kelly K.
    Torres, Keila E.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S466 - S467
  • [7] Long-Term Outcomes of Radiation Therapy (RT) in the Management of Malignant Peripheral Nerve Sheath Tumors (MPNST) in Patients with Neurofibromatosis Type 1 (NF1)
    Sloan, L.
    Terezakis, S. A.
    Blakeley, J. O.
    Slobogean, B.
    Kleinberg, L. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E474 - E475
  • [8] Differentially expressed genes in NF1 associated neurofibromas and malignant peripheral nerve sheath tumors (MPNST)
    Holtkamp, N.
    Gonzalez, M. I. Atallah
    Mautner, V. F.
    Friedrich, R. E.
    Harder, A.
    Hartmann, C.
    Reuss, D.
    Prietz, S.
    Theallier-Janko, A.
    Von Deimling, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 22 - 22
  • [9] Differentially expressed genes in NF1 associated neurofibromas and malignant peripheral nerve sheath tumors (MPNST)
    Holtkamp, N
    González, IA
    Reuss, D
    Pham, VA
    Harder, A
    Hartmann, C
    Mautner, VF
    Friedrich, RE
    Kluwe, L
    Frahm, S
    Mangold, D
    Algermissen, B
    Prietz, S
    Estevez-Schwarz, L
    Schlag, PM
    von Deimling, A
    ACTA NEUROPATHOLOGICA, 2003, 106 (04) : 411 - 411
  • [10] Deregulated microRNAs in NF1 derived malignant peripheral nerve sheath tumors (MPNST) and their role in carcinogenesis
    Amirnasr, Azadeh
    van Kuijk, Patricia F.
    Verdijk, Robert M.
    Taal, Walter
    Sleijfer, Stefan
    Wiemer, Erik A. C.
    CANCER RESEARCH, 2017, 77
12345